Some potentially groundbreaking research on diabetes, a highly prevalent disease on Guam, will be launching soon.

According to an announcement of the planned study, “artificial intelligence will be employed to collect local healthcare data from a variety of sources that can identify critical risk factors and provide insights into treating patients with Diabetes.” Dr. David Klonoff is a leading researcher on the disease, and is on the AI Health Medical Advisory Board.

"When you have data you can use that to make a diagnosis, you can use that to select the best treatment, you can use that to create a prognosis, what's likely to happen, and you can use that information for prevention," he said. "So all those four factors, diagnosis, treatment, prognosis and prevention all stem from monitoring data, analyzing the data and using it to help the patient."

The study is being supported locally by the Guam Regional Medical City, the American Medical Center and Calvo’s SelectCare.  You can watch the full interview with Dr. Klonoff and Dr. Erika Alford on the next edition of IN FULL ZOOM.